Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medpace Holdings Inc (MEDP) vs Star Bulk Carriers Corp (SBLK) Price & Performance

Medpace Holdings IncTrade
Star Bulk Carriers CorpTrade

Price performance (Past 24H)

Key statistics

Medpace Holdings Inc vs Star Bulk Carriers Corp — how do they compare? Medpace Holdings Inc trades at $612.05 (market cap $16.82B), while Star Bulk Carriers Corp trades at $29.7 (market cap $3.54B). The key difference: Medpace Holdings Inc is far larger — about 4.8× Star Bulk Carriers Corp's market cap, and Star Bulk Carriers Corp pays a 6.17% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Star Bulk Carriers Corp for 24 Days on average.

MEDPSBLK
Market Cap
$16.82B$3.54B
Volume
223,0931,437,622
Sector
HealthIndustrials
52-Week High
$630.19$32.49
52-Week Low
$393.42$16.79
Typical Hold Time
14 Days24 Days
Enterprise Value
$16.44B$4.22B
Dividend Yield
—6.17%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Medpace Holdings Inc

Medpace (MEDP) trades at $602.70, down slightly by 0.26% on the day, with a neutral technical outlook and bullish moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results expected on October 21, 2026. Revenue and net income are projected to grow in 2026, supported by a robust 17.67% net income margin and exceptional ROE of 162.15%. However, valuation ratios like P/E of 35.41 and P/B of 38.77 suggest a premium pricing relative to peers.

The stock offers upside to the consensus price target of $620.44, but risks include high valuation multiples, CEO stock sales, and mixed institutional positioning. Investors should weigh strong profitability against potential overvaluation and monitor Q3 earnings for continued momentum.

Star Bulk Carriers Corp

Star Bulk Carriers (SBLK) trades at $30.47, up 2.63% today, with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with Q2 2026 EPS of $1.21 beating expectations by 27%, revenue growth of 45% year-over-year, and attractive valuation metrics including a P/E of 11.95. Recent insider buying by executives and positive analyst coverage (58% buy ratings) signal confidence in the shipping company's prospects.

SBLK presents a compelling value opportunity with strong earnings momentum, 100% free cash flow distribution policy, and $0.90 dividend yield. Key risks include shipping rate volatility and macroeconomic sensitivity, but the company's consistent earnings beats and insider accumulation suggest upside potential. The stock trades near recent highs with solid institutional support.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MEDP
100% Buy0% Sell
Avg holding period · 14 Days
SBLK

No sentiment data available yet.

Top news

Latest headlines on both assets

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP →

About Star Bulk Carriers Corp

Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.

Read more on SBLK →